Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Dipesh Kumar Yadav

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3068-6483; OpenAlex author ID A5091179353. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Co-author DOI 10.1038/s41467-021-24769-3↗
  2. Liquid biopsy in pancreatic cancer: the beginning of a new era. Co-author DOI 10.18632/oncotarget.24809↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 2 shared papers, 2018–2021 · strength 0.20
  2. Jian Xu · 1 shared paper, 2021 · strength 0.12
  3. Gang Zhang · 1 shared paper, 2021 · strength 0.12
  4. Xing Huang · 1 shared paper, 2021 · strength 0.12
  5. Enliang Li · 1 shared paper, 2021 · strength 0.12
  6. Xiaozhen Zhang · 1 shared paper, 2021 · strength 0.12
  7. Mengyi Lao · 1 shared paper, 2021 · strength 0.12
  8. Tianyu Tang · 1 shared paper, 2021 · strength 0.12
  9. Xueli Bai · 1 shared paper, 2021 · strength 0.12
  10. Tao Ma · 1 shared paper, 2018 · strength 0.09
  11. Wei Chen · 1 shared paper, 2018 · strength 0.09
  12. Guogang Li · 1 shared paper, 2018 · strength 0.09
  13. Xueli Bai · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.